During the past decade, Universitäres Krebszentrum Leipzig conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Universitäres Krebszentrum Leipzig" are "Advanced Gastric or EGJ Cancer" (1 trials), "Advanced/Metastatic Breast Cancer" (1 trials), "Breast Cancer (Early Breast Cancer)" (1 trials), "Head and Neck Squamous Cell Carcinoma" (1 trials) and "Metastatic Breast Cancer" (1 trials). Many other conditions were trialed in "Universitäres Krebszentrum Leipzig" in a lesser frequency.

Most popular intervention types in "Universitäres Krebszentrum Leipzig" are "Drug" (2 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "5-FU" (1 trials), "Blood sampling" (1 trials), "Carboplatin" (1 trials), "Cisplatin" (1 trials) and "Docetaxel" (1 trials). Other intervention names were less common.

The vast majority of trials in "Universitäres Krebszentrum Leipzig" are 4 trials for "All" genders.

Currently, there are NaN active trials in "Universitäres Krebszentrum Leipzig". undefined are not yet recruiting, 3 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Universitäres Krebszentrum Leipzig, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Universitäres Krebszentrum Leipzig, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".